Viridian Therapeutics, Inc./DE Other Noncash Income (Expense)
Viridian Therapeutics, Inc./DE (VRDN) reported Other Noncash Income (Expense) of -$169.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-05-05
- Viridian Therapeutics, Inc./DE other noncash income (expense) for the quarter ending 2026-03-31 was -$169.00K, a 2916.67% decline year-over-year.
- Viridian Therapeutics, Inc./DE other noncash income (expense) for the quarter ending 2025-03-31 was $6.00K.
- Viridian Therapeutics, Inc./DE other noncash income (expense) for the quarter ending 2024-12-31 was -$620.00K.
- Viridian Therapeutics, Inc./DE other noncash income (expense) for the quarter ending 2024-09-30 was $0.00.
- Viridian Therapeutics, Inc./DE other noncash income (expense) for fiscal 2025 was -$157.00K.
- Viridian Therapeutics, Inc./DE other noncash income (expense) for fiscal 2024 was -$620.00K.
- Viridian Therapeutics, Inc./DE other noncash income (expense) for fiscal 2023 was -$775.00K.
- Viridian Therapeutics, Inc./DE other noncash income (expense) for fiscal 2022 was $0.00.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-03-31 | -$169.00K 10-Q · filed 2026-05-05 | |||||
| 2025-12-31 | -$157.00K 10-K · filed 2026-02-26 | |||||
| 2025-03-31 | $6.00K 10-Q · filed 2026-05-05 | -$614.00K derived: sum of 2 quarters · filed 2026-05-05 | -$614.00K derived: sum of 3 quarters · filed 2026-05-05 | -$614.00K derived: sum of 4 quarters · filed 2026-05-05 | ||
| 2024-12-31 | -$620.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$620.00K derived: sum of 2 quarters · filed 2026-02-26 | -$620.00K derived: sum of 3 quarters · filed 2026-02-26 | -$620.00K 10-K · filed 2026-02-26 | $0.00 10-K · filed 2025-03-03 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | -$744.00K derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | -$744.00K derived: sum of 3 quarters · filed 2026-02-26 | -$744.00K derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 | -$744.00K derived: sum of 2 quarters · filed 2026-02-26 | -$744.00K derived: sum of 3 quarters · filed 2026-02-26 | -$745.00K derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | -$744.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$744.00K derived: sum of 2 quarters · filed 2026-02-26 | -$745.00K derived: sum of 3 quarters · filed 2026-02-26 | -$775.00K 10-K · filed 2026-02-26 | -$31.00K 10-K · filed 2024-02-27 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$1.00K derived: sum of 2 quarters · filed 2024-11-12 | -$31.00K 10-Q · filed 2024-11-12 | -$31.00K derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2023-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$31.00K 10-Q · filed 2024-08-08 | -$31.00K derived: sum of 3 quarters · filed 2025-03-03 | -$31.00K derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2023-03-31 | -$30.00K 10-Q · filed 2024-05-08 | -$30.00K derived: sum of 2 quarters · filed 2025-03-03 | -$30.00K derived: sum of 3 quarters · filed 2025-03-03 | -$30.00K derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $0.00 derived: sum of 2 quarters · filed 2025-03-03 | $0.00 derived: sum of 3 quarters · filed 2025-03-03 | $0.00 10-K · filed 2025-03-03 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | $0.00 derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-10 | -$47.00K 10-Q · filed 2022-05-13 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 | ||||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-05 | |||||
| 2021-03-31 | $5.00K 10-Q · filed 2022-05-13 | $4.00K derived: sum of 2 quarters · filed 2022-05-13 | $101.00K derived: sum of 3 quarters · filed 2022-05-13 | $56.00K derived: sum of 4 quarters · filed 2022-05-13 | ||
| 2020-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $96.00K derived: sum of 2 quarters · filed 2022-03-11 | $51.00K derived: sum of 3 quarters · filed 2022-03-11 | -$35.00K 10-K · filed 2022-03-11 | ||
| 2020-09-30 | $97.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $52.00K derived: sum of 2 quarters · filed 2021-11-05 | -$34.00K 10-Q · filed 2021-11-05 | -$34.00K derived: sum of 4 quarters · filed 2021-11-05 | ||
| 2020-06-30 | -$45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$131.00K 10-Q · filed 2020-08-05 | -$131.00K derived: sum of 3 quarters · filed 2021-05-07 | -$270.00K derived: sum of 4 quarters · filed 2021-05-07 | ||
| 2020-03-31 | -$86.00K 10-Q · filed 2021-05-07 | -$86.00K derived: sum of 2 quarters · filed 2021-05-07 | -$225.00K derived: sum of 3 quarters · filed 2021-05-07 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | -$139.00K derived: sum of 2 quarters · filed 2021-03-26 | $0.00 10-K · filed 2021-03-26 | |||
| 2019-09-30 | -$139.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | ||||
| 2019-06-30 | $139.00K 10-Q · filed 2020-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |